Search by Drug Name or NDC

    NDC 25208-0001-04 AGGRASTAT 3.75 mg/15mL Details

    AGGRASTAT 3.75 mg/15mL

    AGGRASTAT is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medicure International Inc. The primary component is TIROFIBAN HYDROCHLORIDE.

    Product Information

    NDC 25208-0001
    Product ID 25208-001_09e14425-6dfb-40ba-8bf2-ba9cd28774d8
    Associated GPIs 85153060101310
    GCN Sequence Number 076752
    GCN Sequence Number Description tirofiban HCl monohydrate VIAL 3.75 MG/15 INTRAVEN
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 42532
    HICL Sequence Number 018386
    HICL Sequence Number Description TIROFIBAN HCL MONOHYDRATE
    Brand/Generic Brand
    Proprietary Name AGGRASTAT
    Proprietary Name Suffix n/a
    Non-Proprietary Name TIROFIBAN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 3.75
    Active Ingredient Units mg/15mL
    Substance Name TIROFIBAN HYDROCHLORIDE
    Labeler Name Medicure International Inc
    Pharmaceutical Class Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020912
    Listing Certified Through 2024-12-31

    Package

    NDC 25208-0001-04 (25208000104)

    NDC Package Code 25208-001-04
    Billing NDC 25208000104
    Package 1 VIAL, GLASS in 1 CARTON (25208-001-04) / 15 mL in 1 VIAL, GLASS
    Marketing Start Date 2016-10-15
    NDC Exclude Flag N
    Pricing Information N/A